In-person

We were delighted to attend the 53rd OPRD conference in Charleston in 2025. The conference provided a platform for sharing scientific content around improving efficiency and learning how to be more innovative in synthetic route design, development and optimisation. The chemical and pharma industries are fast moving and ever changing and the efficient conversion of

Nitrosamines are emerging as a significant concern in the pharmaceutical industry, posing regulatory and safety challenges for manufacturers. Are you prepared to address these risks effectively? Our panel of expert speakers discussed why nitrosamines have become a growing concern and the latest regulatory developments in Argentina and Mexico. This webinar also introduced innovative in silico

We were delighted to be on the programme at the 10th Winter Process Chemistry Conference. Lhasa Principal Scientist Michael Burns presented ‘Reactivities of N-nitrosamines against Common Reagents and Reaction Conditions’. The 10th Winter Process Conference showcased presentations from International Chemists covering all aspects of Process Development. The speakers discussed the latest issues in synthetic route design,

Japan The 53rd Annual Meeting of the Society of Environmental Mutagen Genomics (JEMS) was held for two days on Saturday, December 7 and Sunday, December 8, 2024 at Shuji University (Okayama City). We were thrilled to participate in the annual conference of the Japanese Environmental Mutagen and Genome Society (JEMS). Since its inception in 1972,

We were delighted to be on the programme at the Annual Meeting of the Japan Society for Alternative Methods of Animal Experimentation (JSAAE), held at Light Cube Utsunomiya for three days from November 29 – December 1 2024. The Japan Society for Alternative Methods of Animal Experimentation is an academic organization that conducts research, development,

We were excited to attend the American College of Toxicology (ACT) 2024 annual meeting in Austin, Texas! ACT is a global community of professional scientists representing the pharmaceutical and biotech industries, regulatory agencies, contract research organizations, academia, and consulting firms. The 45th Annual Meeting  included a wide-ranging scientific program and educational courses, with distinguished plenary

We’re excited to return to India for the Lhasa 2025 Hyderabad Symposium on Thursday, 6th November, Join us for this free, one-day event, where industry and regulatory experts will share insights on ICH M7, Nitrosamines, Purge Calculations, and more. To secure your spot, join the waiting list via the event page and we’ll be in

We were thrilled to host a Lhasa Limited Symposium in Shanghai, China, alongside CloudScientific. On 17th October 2024, we brought together professionals from industry to address critical topics on on impurity assessment and control in drug development and manufacturing. The event offered valuable insights from experts on ICH M7 assessment, process and degradation impurities, and

We were thrilled to host another Lhasa Limited Symposium in Seoul, South Korea, alongside BITEK CHEMS. On 15th October 2024, we brought together professionals from industry and regulatory bodies to address critical topics in chemical safety, with a particular focus on the ongoing challenges of nitrosamine risk assessment. The event offered valuable insights from experts